Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGRGet Rating) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the medical device company’s stock.

Separately, HC Wainwright initiated coverage on shares of Avinger in a report on Friday, April 21st. They issued a “buy” rating for the company.

Avinger Price Performance

AVGR stock opened at $0.59 on Friday. The business has a 50-day moving average price of $0.64 and a 200 day moving average price of $1.00. The company has a market capitalization of $6.28 million, a P/E ratio of -0.19 and a beta of 1.52. Avinger has a 1-year low of $0.42 and a 1-year high of $2.14.

Avinger (NASDAQ:AVGRGet Rating) last announced its earnings results on Wednesday, March 15th. The medical device company reported ($0.70) EPS for the quarter. The firm had revenue of $2.00 million during the quarter. Avinger had a negative return on equity of 530.21% and a negative net margin of 207.02%. On average, analysts anticipate that Avinger will post -1.21 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Avinger

Large investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC bought a new position in Avinger in the second quarter worth about $42,000. Dimensional Fund Advisors LP acquired a new position in shares of Avinger during the first quarter valued at about $64,000. Finally, Armistice Capital LLC acquired a new position in shares of Avinger during the third quarter valued at about $768,000. 14.14% of the stock is currently owned by institutional investors.

About Avinger

(Get Rating)

Avinger, Inc is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat.

Featured Stories

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.